In this issue:
Abiraterone + prednisone + ADT in newly diagnosed high-risk mCSPC
Patient-reported outcomes with enzalutamide in nmCRPC
Docetaxel plus ADT in high-risk prostate cancer
Quality of life with hypofractionated vs conventional radiotherapy
Self-management in long-term prostate cancer survivors
PROSTVAC in mCRPC
Androgen receptor splice variant 7 in mCRPC
Circulating microRNA profiling for diagnosing prostate cancer
Dietary fat and prostate cancer risk
Prostate HistoScanning for prostate cancer risk evaluation
Please login below to download this issue (PDF)